Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies

Bone Marrow Transplantation volume 26, pages 211–214 (2000)Cite this article

Abstract

The risk and outcome of infection in febrile neutropenic patients is mainly determined by the duration of neutropenia, the underlying disease or the treatment. This study was undertaken to compare infections and the outcome after conventional chemotherapy (CCT), allogeneic PBSC transplantation (alloPBSCT) or autologous PBSC transplantation (autoPBSCT), during the period of neutropenia, in a single center. A total of 145 patients (50 in CCT group, 50 in alloPBSCT and 45 in autoPBSCT) were evaluated. In the alloPBSCT group, 86% of the patients (43/50), in the autoPBSCT group 93% of the patients (42/45) and in the CCT group 92% (46/50) of the patients had at least one febrile episode during their neutropenic period (P > 0.05). Microbiologically and/or clinically documented infection rates were 50% (25/50), 42% (19/45) and 48% (24/50) respectively. Gram-positive pathogens, mostly coagulase-negative staphylococci were the most frequent cause of bacteremias in all groups. The frequency of CNS infections was significantly higher in the alloPBSCT and autoPBSCT groups compared to the CCT group (P < 0.008 and P < 0.04, respectively). Catheter infections were frequent in the pbsct groups and pulmonary infections were more frequent in the cct group (P < 0.05). The CCT group needed longer antibiotic usage compared to the alloPBSCT group (P < 0.006). The duration of neutropenia and the type of treatment given, does not affect the rate of febrile episodes, but affects the type of infections in febrile neutropenic patients. Bone Marrow Transplantation (2000) 26, 211–214.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Pizzo PA, Meyers JD, Freifeld AG, Walsh T . Infections in the Cancer Patient. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer JB Lippincott: Philadelphia 1993 pp2292–2337

    Google Scholar 

  2. Kern VW, Cometta A, DeBock R et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy New Engl J Med 1999 341: 312–318

    Article  CAS  Google Scholar 

  3. Gaya H, Klastersky J . Empirical therapy for bacterial infections in neutropenic patients Turk J Haematol 1998 15: 3–15

    Google Scholar 

  4. Akan H, Koç H, Arslan Ö et al. Febrile neutropenia in a bone marrow transplantation unit Int J Antimicrob Agent 1997 8: 127–130

    Article  CAS  Google Scholar 

  5. Klastersky J, Zinner SH, Calandra T et al. Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials Eur J Cancer Clin Oncol 1988 24: 35–45

    Article  Google Scholar 

  6. Uderzo C, D'Angelo P, Rizzari C et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies Bone Marrow Transplant 1992 9: 113–117

    CAS  PubMed  Google Scholar 

  7. Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 143–147

    Article  CAS  Google Scholar 

  8. Maschmeyer G, Link H, Hiddeman W et al. Pulmonary infiltration in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomize multicenter study Cancer 1994 73: 2296–2304

    Article  CAS  Google Scholar 

  9. Larsson K, Bjorkstrand B, Ljungman P . Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation Support Care Cancer 1998 4: 378–383

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Ankara University, Faculty of Medicine, Ankara, Turkey

    H Çelebi, H Akan, E Akçağlayan, C Üstün & M Arat

Authors
  1. H Çelebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Akan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Akçağlayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Üstün
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Arat
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Çelebi, H., Akan, H., Akçağlayan, E. et al. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 26, 211–214 (2000). https://doi.org/10.1038/sj.bmt.1702503

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702503

Keywords

This article is cited by

Search

Advanced search

Quick links